All News

Riluzole oral film is a novel formulation of riluzole, which is an adjuvant therapy for amyotrophic lateral sclerosis.

Approved by the FDA on April 9, 2019, Amgen’s romosozumab-aqqg therapy (Evenity) is indicated for osteoporosis in postmenopausal women at high risk for fracture, defined as a history of osteoporotic fracture, or multiple risk factors for fracture; or patients who have failed or are intolerant to other available osteoporosis therapy.

Study finds a dramatic difference between guidelines for tests such as mammograms and colon cancer screenings between the United Kingdom and the United States.

Top news of the day from across the health care landscape.

The vaccine will use a cell-based candidate vaccine virus (CVV) for 4 influenza strains identified by the World Health Organization (WHO) for the upcoming flu season.

Estimates suggest that by 2020, 1.5 to 1.75 million people in the U.S. will be living with wet AMD, a leading cause of blindness worldwide and a rapidly growing public health concern, according to Novartis.

Glecaprevir/pibrentasvir (G/P) plus sofosbuvir and ribavirin can potentially treat patients who experienced previous virologic failure following G/P therapy.

Officials with the US Food and Drug Administration have approved a therapy designed to provide weight management aid to overweight adults.

Changing patient habits, especially dietary habits, is a routine struggle for many people diagnosed with type 2 diabetes.

Top news of the day from across the health care landscape.

Why is this patient listing ciprofloxacin as an allergy?

If this new indication is approved, Invokana® would be the first diabetes medication to treat both T2D and CKD.

Kratom is a plant native to Southeast Asia which can produce stimulant and opioid-like effects.

Official with the FDA today granted accelerated approval to erdafitinib (Balversa, Janssen) for adult patients with locally advanced or metastatic bladder cancer.

Bladder cancers are associated with genetic mutations that are present in the patient's bladder or entire the lining of the lower urinary tract.

A study, which tested naturally occurring homoisoflavonoids found in the Hyacinthaceae plant family and their synthetic derivatives, focused on the abnormal growth of new blood vessel cells in the eye that are linked to types of blindness.

The expanded first-line indication makes pembrolizumab (Keytruda) monotherapy an option for more patients with non-small cell lung cancer.

Top news of the week from Specialty Pharmacy Times.

Top news of the day from across the health care landscape.

The expanded first-line indication makes pembrolizumab (Keytruda) monotherapy an option for more patients with non-small cell lung cancer.

The expansion of the Valyou Savings Program helps to address the challenge many patients face regarding unpredictable and unaffordable pricing for their insulin, according to the company.

The action requires the company to revise safety information that women and their health care professionals need when considering use of the drug.

There are currently firms working to use artificial intelligence in hopes that it could contribute to minimizing the impact of the opioid epidemic.

The supplement (Equelle, Pharmavite) relies on S-equol, an intestinal bacterial metabolite of the soybean isoflavone daidzein that binds to select estrogen receptors in the body.

Across the United States, 5090 individuals were matched to approximately 2500 pharmacy residency programs.

Cytomegalovirus may contribute to faster cystic fibrosis progression, but further studies are warranted to confirm these findings.

Top news of the day from across the health care landscape.

The 4-drug combination tablet (Symtuza) was approved by the FDA in July 2018 for infection of HIV type 1 (HIV-1) in treatment-naïve and certain virologically suppressed adults.